Beating a retreat

6 Dec 2016 By Rachel Morarjee

Selling U.S. insurer Ironshore is a welcome sign of caution from one of China’s most aggressive dealmakers. The deal will shore up Fosun’s balance sheet and sharpen its focus on emerging markets. The U.S. will only become tougher for Chinese firms to navigate.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)